Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Transfusion. 2020 Mar;60(Suppl 2):S17–S37. doi: 10.1111/trf.15715

TABLE 5.

Estimated number of donors and deferrals in the United States, 2017 (expressed in thousands)*

2017 % of total deferrals


Males Females Total (95% CI) Total, 2015 2017 2015 % change 2017–2015
Donor deferrals
 Low hemoglobin/hematocrit 208 907 1115 (1051–1179) 975 43.8 51.7 14.3
 Prescription drug use 28 28 56 (49–62) 54 2.2 2.9 3.1
 Pulse and/or blood pressure 134 154 288 (261–315) 11.3
 Other medical reasons 203 319 523 (442–603) 504 20.5 26.7 3.7
 High-risk behavior, MSM only§ 6 0 6 (5–7) 8 0.2 0.4 −25.8
 High-risk behavior, all other behaviors 11 9 20 (18–23) 16 0.8 0.9 27.6
 Travel 56 58 114 (103–124) 113 4.5 6 0.7
 Tattoo/piercing 19 42 61 (55–67) 49 2.4 2.6 25.1
 Other non-medical reasons 125 176 301 (264–338) 166 11.8 8.8 81.4
Total deferrals 862 1683 2544 (2373–2716) 1886
Total presenting to donate 7099 6919 14,018 (13,132–14,903) 15,111
*

Excludes directed and autologous donors.

Donors deferred for low hemoglobin included those that do not meet the current FDA blood hemoglobin level requirements for blood donation.

Other medical reasons may include the use of medications on the medication deferral list, growth hormone from human pituitary glands, Hepatitis B Immune Globulin (HBIG), unlicensed vaccines, or presenting with physical conditions or symptoms that do not qualify a person to be a blood donor.

§

High-risk behavior deferrals include deferrals intended to reduce the risk of transmission of infectious diseases including HIV and hepatitis viruses. Examples of questions intended to identify these risks are sexual contact (men who have sex with men [MSM]) and non-medical injection drug use questions.

Travel deferrals are deferrals for travel to a specific region of the world.

Total presenting to donate in 20155 excluded total deferrals and is corrected here to be consistent with the 2013 and 2017 estimates.